News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/vials_drug_Bill_Branson_230.jpg)
FDA approves biosimilar rituximab for NHL
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/jivi_bayer-210.jpg)
EC approves product for hemophilia A
- Author:
- HT Staff
The European Commission (EC) has approved damoctocog alfa pegol (Jivi®), a recombinant human factor VIII therapy. Damoctocog alfa pegol (formerly...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/mycosis_fungoides_micrograph_showing_230.jpg)
EC approves mogamulizumab for MF, SS
- Author:
- HT Staff
The European Commission (EC) has granted marketing authorization for mogamulizumab (Poteligeo), a humanized monoclonal antibody directed against...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/adynovate-baxalta-230.png)
Canada expands approval for antihemophilic factor
- Author:
- HT Staff
Health Canada has extended the approved indication for Adynovate, a recombinant pegylated factor VIII (FVIII) product, in patients with hemophilia...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/cancer-pt-nurse-rhoda-baer-220.jpg)
Pegfilgrastim biosimilar approved by EC
- Author:
- HT Staff
The European Commission (EC) has granted marketing authorization for Sandoz’s pegfilgrastim product Ziextenzo®, a biosimilar of Amgen’s Neulasta...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/bone_marrow_harvest_Credit_Chad_McNeeley_230.jpg)
Older people with CHIP are safe donor source for HSCT
- Author:
- HT Staff
New research suggests older individuals with clonal hematopoiesis of indeterminate potential (CHIP) are a safe donor source for allogeneic...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/young_adult_pt_receiving_chemo_Credit_Rhoda_Baer_220.jpg)
EC approves pegfilgrastim biosimilar
- Author:
- HT Staff
The European Commission (EC) has approved Mundipharma’s pegfilgrastim product Pelmeg, a biosimilar of Amgen’s Neulasta. Pelmeg is approved for...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/AML-paulo-henrique-orlandi-mourao-210.jpg)
FDA grants priority review to quizartinib
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/ASH2017-attendees-credit-ASH-220.jpg)
ASH expands late-breaking abstract session
- Author:
- HT Staff
An additional presentation has been added to the late-breaking abstract session of the 2018 ASH Annual Meeting. The session was expanded from six...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/money-hand-junior-libby-230.jpg)
Americans concerned about cost of cancer care
- Author:
- HT Staff
A recent survey suggests Americans are nearly as worried about the cost of a cancer diagnosis as they are about dying from cancer. The cost of...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/blinatumomab-vials-blincyto-amgen-220.jpg)
CHMP backs blinatumomab for MRD
- Author:
- HT Staff
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding marketing authorization for...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/eltrombopag-GSK-220.jpg)
Eltrombopag approved as first-line SAA therapy
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/brentuximab-vedotin-businesswire-230.png)
Quick FDA approval for brentuximab vedotin in PTCL
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/arsenic-trioxide-fesenius-kabi-220.jpg)
FDA approves generic drugs for APL
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/MDS_blood_smear.jpg)
FDA approves generic decitabine for MDS
- Author:
- HT Staff
The U.S. Food and Drug Administration has approved Lupin’s decitabine product, a generic version of Otsuka Pharmaceutical Co.